CVA Family Office, LLC
Family OfficePosition in BMY — Bristol Myers Squibb Co
CIK 1802084
DENVER, CO
Position in BMY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$536,211
-$62,343 QoQ
Shares Held
9,306
-5.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,490
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. BMY ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,076 | $3,689,446 | |
| 2 | JNJ |
Johnson & Johnson
|
9,737 | $2,472,905 | |
| 3 | AMGN |
Amgen Inc
|
4,049 | $1,466,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,140 | $1,431,490 | |
| 5 | ABBV |
AbbVie Inc.
|
4,882 | $1,228,506 | |
| 6 | NVS |
Novartis AG
|
5,542 | $868,542 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
9,306 | $536,211 | |
| 8 | GSK |
GSK plc
|
8,000 | $419,360 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $536,211 | 9,306 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $598,554 | 9,869 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $454,228 | 8,421 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $404,050 | 8,959 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $404,389 | 8,736 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $577,514 | 9,469 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $532,173 | 9,409 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $451,379 | 8,724 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $331,949 | 7,993 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $366,811 | 6,764 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $156,495 | 3,050 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $206,448 | 3,557 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $255,927 | 4,002 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $274,259 | 3,957 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $318,162 | 4,422 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $336,184 | 4,729 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $396,627 | 5,151 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $357,773 | 4,899 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $258,503 | 4,146 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $106,683 | 1,803 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $272,625 | 4,080 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $199,048 | 3,153 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $181,747 | 2,930 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $108,702 | 1,803 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $64,092 | 1,090 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $27,870 | 500 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||